Legal Opinion
Introduction
-
Our firm, Jiangsu Century Tongren Law Firm, has been entrusted by Jinghua Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Jinghua Pharmaceutical" or "the Company") to issue this legal opinion regarding the adjustment of the grant of restricted stocks under the 2025 Restricted Stock Incentive Plan (hereinafter referred to as "the Incentive Plan" or "this Incentive Plan").
-
This opinion is based on the provisions of the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Administrative Measures for Equity Incentives of Listed Companies, and other relevant laws and regulations.
-
The firm has conducted due diligence and verified the facts as of the date of this opinion, ensuring that the conclusions drawn are lawful and accurate.